Revenue
No reported data
REGENTIS BIOMATERIALS LTD. (RGNT)
Price—Loading quote
Net income
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Operating income | −$7.0M | $932,000 | −$1.9M |
| Net income | −$13.6M | $4.8M | −$4.1M |
| Basic EPSper diluted share | -$24.16 | $1.72 | -$24.09 |
| Diluted EPSper diluted share | -$24.16 | $1.72 | -$24.09 |